The DOI matches its Crossref record.
Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys
Open accessAbstract
The development of a vaccine for tuberculosis requires a combination of antigens and adjuvants capable of inducing appropriate and long-lasting T cell immunity. We evaluated Mtb72F formulated in AS02A in the cynomolgus monkey model. The vaccine was immunogenic and caused no adverse reactions. When monkeys were immunized with bacillus Calmette–Guérin (BCG) and then boosted with Mtb72F in AS02A, protection superior to that afforded by using BCG alone was achieved, as measured by clinical parameters, pathology, and survival. We observed long-term survival and evidence of reversal of disease progression in monkeys immunized with the prime-boost regimen. Antigen-specific responses from protected monkeys receiving BCG and Mtb72F/AS02A had a distinctive cytokine profile characterized by an increased ratio between 3 Th1 cytokines, IFN-γ, TNF, and IL-2 and an innate cytokine, IL-6. To our knowledge, this is an initial report of a vaccine capable of inducing long-term protection against tuberculosis in a nonhuman primate model, as determined by protection against severe disease and death, and by other clinical and histopathological parameters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Tuberculosis: What We Don’t Know Can, and Does, Hurt Us
Russell, D. G., Barry, C. E., & Flynn, J. L. (2010) · Science · doi:10.1126/science.1184784 · Cited by 489
Use of defined TLR ligands as adjuvants within human vaccines
Duthie, M. S., Windish, H. P., Fox, C. B., & Reed, S. G. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00978.x · Cited by 437
Self-citationQuantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model
Lin, P. L., Rodgers, M., Smith, L., Bigbee, M., Myers, A., Bigbee, C., Chiosea, I., Capuano, S. V., Fuhrman, C., Klein, E., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00592-09 · Cited by 425
Kagina, B. M. N., Abel, B., Scriba, T. J., Hughes, E. J., Keyser, A., Soares, A., Gamieldien, H., Sidibana, M., Hatherill, M., Gelderbloem, S., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0334oc · Cited by 402
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
Garçon, N., & Van Mechelen, M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.29 · Cited by 314
Metadata
- Authors
- Reed, S. G., Coler, R. N., Dalemans, W., Tan, E. V., DeLa Cruz, E. C., Basaraba, R. J., Orme, I. M., Skeiky, Y. A. W., Alderson, M. R., Cowgill, K. D., Prieels, J.-P., Abalos, R. M., Dubois, M.-C., Cohen, J., Mettens, P., & Lobet, Y.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-02-17
- Volume
- 106
- Issue
- 7
- Pages
- 2301-2306
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2009737104
- Cited by
- 167
- References
- 0
- FWCI
- 13.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys. https://app.cochat.ai/papers/10.1073/pnas.0712077106
- The paper
- Reed, S. G., Coler, R. N., Dalemans, W., Tan, E. V., DeLa Cruz, E. C., Basaraba, R. J., Orme, I. M., Skeiky, Y. A. W., Alderson, M. R., Cowgill, K. D., Prieels, J.-P., Abalos, R. M., Dubois, M.-C., Cohen, J., Mettens, P., & Lobet, Y. (2009). Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0712077106
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.